Products for Research Use Only

TGFBR1-IN-2

CAT: 0804-HY-164793-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-164793-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TGFBR1-IN-2 (Compound AQA) is a TGFBR1 inhibitor and an antibacterial agent. TGFBR1-IN-2 is a substrate for cytochrome P450s. TGFBR1-IN-2 contains the pyridyl-6-methyl moiety necessary for Mycobacterium tuberculosis inhibition and has potent inhibitory activity against non-replicating and persistent Mycobacterium tuberculosis[1].
CAS Number
733806-89-8
UNSPSC
12352005
Target
Bacterial; Cytochrome P450; TGF-β Receptor
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/tgfbr1-in-2.html
Purity
98.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=NC(C2=NC(NC3=CC=NC=C3)=C4C=CC=CC4=N2)=CC=C1
Molecular Formula
C19H15N5
Molecular Weight
313.36
References & Citations
[1]Nandakumar, et al. Dual Inhibition of Mycobacterium tuberculosis and the Host TGFBR1 by an Anilinoquinazoline. Journal of medicinal chemistry. 2023, 66 (21) :14724-14734.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported